NZ590332A - Combination of antibody 224G11 and PF-2341066 for the treatment of cancer - Google Patents
Combination of antibody 224G11 and PF-2341066 for the treatment of cancerInfo
- Publication number
- NZ590332A NZ590332A NZ590332A NZ59033209A NZ590332A NZ 590332 A NZ590332 A NZ 590332A NZ 590332 A NZ590332 A NZ 590332A NZ 59033209 A NZ59033209 A NZ 59033209A NZ 590332 A NZ590332 A NZ 590332A
- Authority
- NZ
- New Zealand
- Prior art keywords
- antibody
- cancer
- treatment
- combination
- composition
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20080305387 EP2143441A1 (en) | 2008-07-08 | 2008-07-08 | Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer |
US7200809A | 2009-07-08 | 2009-07-08 | |
PCT/EP2009/058709 WO2010003992A1 (en) | 2008-07-08 | 2009-07-08 | Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ590332A true NZ590332A (en) | 2012-08-31 |
Family
ID=46755255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ590332A NZ590332A (en) | 2008-07-08 | 2009-07-08 | Combination of antibody 224G11 and PF-2341066 for the treatment of cancer |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ590332A (en) |
-
2009
- 2009-07-08 NZ NZ590332A patent/NZ590332A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011000255A (en) | Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer. | |
WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
UA104585C2 (en) | Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof | |
MY166014A (en) | Combination therapy methods for treating proliferative diseases | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
GB201118656D0 (en) | New compounds | |
WO2014062720A3 (en) | Methods of treating cancer | |
MX361542B (en) | Morphinan compounds. | |
IN2012DN02018A (en) | ||
MX2013012253A (en) | Novel binder-drug conjugates (adcs) and their use. | |
MX2007009649A (en) | Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer. | |
MX2009006786A (en) | Compositions and methods for the treatment of infections and tumors. | |
AU2010266004A8 (en) | Method of treating cancer with Dll4 antagonist and chemotherapeutic agent | |
BR112014031394A2 (en) | compositions and methods for transmucosal absorption | |
EA201490377A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKVINIMODE AND GLATIRAMER ACETATE | |
MX2014002171A (en) | Combination treatments for hepatitis c. | |
EA201170753A1 (en) | NALMEPHENA HYDROCHLORIDE DIHYDRATE | |
UA111599C2 (en) | COMPOSITION OF CASPOFUNGIN | |
MX2009005946A (en) | Combination. | |
MX2011006725A (en) | Combination of aurora kinase inhibitors and anti-cd20 antibodies. | |
MX2013000694A (en) | Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease. | |
WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
EA201270747A1 (en) | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF THE RAS | |
WO2013096335A8 (en) | ADMINISTRATION OF AN ANTAGONIST OF α5β1 FOR ANTI-ANTIOGENESIS AND CANCER TREATMENT | |
WO2009108755A3 (en) | Pharmaceutical combinations for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 08 JUL 2016 BY ACUMASS Effective date: 20130624 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2017 BY ACUMASS Effective date: 20160624 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2018 BY ACUMASS Effective date: 20170624 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2019 BY ACUMASS Effective date: 20180626 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2020 BY ACUMASS Effective date: 20190619 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2021 BY ACUMASS Effective date: 20200618 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2022 BY ACUMASS Effective date: 20210618 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2023 BY ACUMASS Effective date: 20220620 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2024 BY ACUMASS Effective date: 20230621 |